News
The SERENITY At-Home Phase 3 trial is a double-blind, placebo-controlled study designed to evaluate the safety of a 120 mcg dose of BXCL501 for the acute treatment of agitation associated with bipolar ...
Pemvidutide is the only drug currently granted Fast Track Designation in AUD ...
Cardiovascular disease is the leading cause of premature deaths in patients with bipolar disorder worldwide. In a novel study ...
News Medical on MSN7h
Young adults with bipolar disorder show signs of early heart dysfunction
Despite accumulating evidence that cardiovascular disease risk increases during the early stages of bipolar disorder, few ...
Philadelphia, August 19, 2025 – Cardiovascular disease is the leading cause of premature deaths in patients with bipolar disorder worldwide. In a ...
Cardiovascular disease is the leading cause of premature deaths in patients with bipolar disorder worldwide. In a novel study ...
Each organ in the human body contains different types of cells arranged in specific ways.These arrangements aid protein interactions, which drive ...
Stockhead on MSN21h
Health Check: CSL turns to a vaccines demerger in an ‘urgent’ get-fit drive
Recognising that the company's performance hasn't been up to scratch, CSL's management has unveiled an "urgent" cost-cutting ...
10hon MSN
Global study warns hepatitis B care must be overhauled to meet WHO 2030 elimination targets
The first global systematic review and meta-analysis of hepatitis B care has found critical patient losses at every step of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback